The
ENERGY study is for adults (ages 18 and up) with warm Autoimmune Hemolytic
Anemia (wAIHA) who are currently receiving treatment or have previously received
treatment. The
goal of the study is to see if the study drug, Nipocalimab is safe and
effective in the treatment of wAIHA. Nipocalimab is an investigational
medication designed to stop your immune system from destroying your red blood cells.

You may be able to join the study if you are:

•          18 years of age or older.
•          Diagnosed with wAIHA for at least 3
  months.
•          Currently receiving treatment or
  have previously received treatment for wAIHA
•          Have platelet counts of more than
  30,000/ L and Hemoglobin less than 10 g/dL

 Other study
requirements will apply.